Document is current
Any future updates will be listed below
-
Authors
Traboulsi-Garet, Bassel
Jorba-García, Adrià
Camps-Font, Octavi
Alves, Fabio Abreu
Figueiredo, Rui https://orcid.org/0000-0002-2122-6530
Valmaseda-Castellón, Eduard
- License Information
-
More Information
Article History
Received: 22 August 2021
Accepted: 11 January 2022
First Online: 6 February 2022
Declarations
:
: This article does not report on any studies with human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.
: Dr. Octavi Camps-Font has participated as a sub-investigator in clinical trials sponsored by Mundipharma (Cambridge, UK) and Menarini Richerche (Florence, Italy). Dr. Camps-Font also reports grants and non-financial support from Avinent (Santpedor, Spain) outside the submitted work. Dr. Rui Figueiredo reports grants, personal fees, and non-financial support from Dentaid SL (Cerdanyola del Vallés, Spain), MozoGrau (Valladolid, Spain), Avinent (Santpedor, Spain) and personal fees from BioHorizons Ibérica (Madrid, Spain), Inibsa Dental (Lliça de Vall, Spain), Dentsply implants Iberia (Barcelona, Spain), and ADIN Implants (Afula, Israel) outside the submitted work. Dr. Figueiredo has also participated as a principal investigator in a randomized clinical trial sponsored by Mundipharma (Cambridge, UK) and in another clinical trial as a sub-investigator for Menarini Richerche (Florence, Italy). Dr. Eduard Valmaseda-Castellón reports personal fees and non-financial support from MozoGrau (Valladolid, Spain) and Avinent (Santpedor, Spain) and personal fees from BioHorizons Ibérica (Madrid, Spain), Inibsa Dental (Lliça de Vall, Spain), and Dentsply implants Iberia (Barcelona, Spain) outside the submitted work. Dr. Valmaseda-Castellón has also participated as a sub-investigator in a randomized clinical trial sponsored by Mundipharma (Cambridge, UK). Bassel Traboulsi-Garet, Adrià Jorba-García, and Dr. Fabio Abreu Alves declare no competing interests.
